Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to identify if healthy cookies high in linoleic acid can change sleep quality and sleep architecture, blood fatty acid composition and be consumed with high compliance after eight weeks of consumption. The hypothesis is that consumption of healthy cookies for 8 weeks will improve sleep quality, increase linoleic acid in the blood and be consumed with greater than 80% compliance.
Overall, linoleic acid has many health benefits including altering body composition and energy metabolism, but is not clear if linoleic acid consumption can influence sleep quality.
The investigators plan to test the central hypothesis and accomplish the overall objective of this research by pursuing the following specific aims
Aim 1) To determine the effect of healthy cookies made with linoleic acid-rich oil on measures of sleep quality and sleep architecture in overweight adults
Aim 2) To determine the effect on plasma fatty acid composition and markers of circadian rhythm in peripheral blood mononuclear cells (PBMC) after four and eight weeks of consuming one healthy cookie per day
Aim 3) To measure the effect of healthy cookies made with LA-oil on change of lipidomic profiles of plasma and PBMC after four and eight weeks of consumption
Aim 4) To determine the feasibility of adherence to consuming 1 healthy cookie per day in place of snack for eight weeks
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy Cookie Group | Experimental | All participants in the study |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| High Linoleic Acid Healthy Cookies | Other | High Linoleic Acid Healthy Cookies (containing about 9g of linoleic acid) 1 per day for 8 weeks |
|
| Measure | Description | Time Frame |
|---|---|---|
| Changes in sleep quality using the Pittsburgh Sleep quality index, PROMIS Sleep questionnaire, and insomnia severity index questionnaire | Changes in global sleep quality scores using the Pittsburgh sleep quality index PROMIS Sleep questionnaire, and insomnia severity index measurements | Week 0, week 4 and week 8 |
| Feasibility of daily healthy cookie consumption | Percent of healthy cookies consumed | Week 8 |
| Changes in blood fatty acids | Changes in linoleic acid levels in the blood | Week 0, week 4 and week 8 |
| Changes in markers of circadian rhythm | Changes in mRNA expression of genes related to circadian rhythm in peripheral blood mononuclear cells | Week 0, week 4 and week 8 |
| Changes in blood lipidomic profiles | Changes in linoleic acid oxylipins in plasma and cardiolipin in peripheral blood mononuclear cells | Week 0, week 4 and week 8 |
| Changes in activity during waking and sleeping hours using an actigraph | Changes in activity during waking and sleeping hours each day will be measured using actigraphy | Week 0, week 4 and week 8 |
| Changes in sleep electroencephalography (EEG) | Changes in sleep EEG will be measured to determine sleep efficiency, arousal index, total sleep time |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in body shape using body mass index (calculated using height and weight) and abdominal thickness | Changes in body mass index and sagittal diameter | Week 0 and week 8 |
| Changes in marker of glycemia |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Martha Belury, Ph.D., RD | Contact | 614-292-1680 | belury.1@osu.edu | |
| Rachel Cole, M.S., RD | Contact | 614-247-8235 | cole.311@osu.edu |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012893 | Sleep Wake Disorders |
| ID | Term |
|---|---|
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Week 0, week 4 and week 8 |
Changes in glucose and insulin
| Week 0, week 4 and week 8 |
| Changes in markers of muscle function using gait speed and grip strength | Changes in grip (hand strength) and gait (walking) speed | Week 0 and week 8 |
| Changes in markers of inflammation | Changes in interleukin 6, tumor necrosis factor receptor 2, C-reactive protein | Week 0, week 4 and week 8 |
| D001523 | Mental Disorders |